Last reviewed · How we verify

NCT07302464

Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

Completed Last updated 24 December 2025
What this trial tests

trial testing Sodium Glucose Co-Transporter 2 Inhibitors in Sodium Glucose Co-Transporter 2 Inhibitors in 60 participants. Completed in 1 June 2025.

Timeline
1 October 2024
Primary endpoint
1 June 2025
1 June 2025

Quick facts

Lead sponsorAin Shams University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date1 October 2024
Primary completion1 June 2025
Estimated completion1 June 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Sodium Glucose Co-Transporter 2 Inhibitors or Estimated Glomerular Filtration Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The work aimed to compare the effects of Sodium-glucose co-transporter-2 (SGLT2) inhibitors on glomerular filtration rate (GFR) in patients with diabetic chronic kidney disease (CKD) and non-diabetic CKD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07302464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing